- Home
- BON vs ALZN Comparison
BON vs ALZN Comparison
Compare BON & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BON
- ALZN
- Stock Information
- Founded
- BON 2006
- ALZN 2016
- Country
- BON China
- ALZN United States
- Employees
- BON N/A
- ALZN N/A
- Industry
- BON Medicinal Chemicals and Botanical Products
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- BON Health Care
- ALZN Health Care
- Exchange
- BON Nasdaq
- ALZN Nasdaq
- Market Cap
- BON 7.9M
- ALZN 9.0M
- IPO Year
- BON 2021
- ALZN 2021
- Fundamental
- Price
- BON $1.90
- ALZN $2.55
- Analyst Decision
- BON
- ALZN Strong Buy
- Analyst Count
- BON 0
- ALZN 1
- Target Price
- BON N/A
- ALZN $42.00
- AVG Volume (30 Days)
- BON 103.9K
- ALZN 117.8K
- Earning Date
- BON 01-30-2026
- ALZN 12-11-2025
- Dividend Yield
- BON N/A
- ALZN N/A
- EPS Growth
- BON N/A
- ALZN N/A
- EPS
- BON 2.46
- ALZN N/A
- Revenue
- BON $21,610,848.00
- ALZN N/A
- Revenue This Year
- BON $223.38
- ALZN N/A
- Revenue Next Year
- BON $18.82
- ALZN N/A
- P/E Ratio
- BON $0.76
- ALZN N/A
- Revenue Growth
- BON N/A
- ALZN N/A
- 52 Week Low
- BON $1.14
- ALZN $2.06
- 52 Week High
- BON $73.75
- ALZN $15.21
- Technical
- Relative Strength Index (RSI)
- BON 48.17
- ALZN 56.64
- Support Level
- BON $1.76
- ALZN $2.38
- Resistance Level
- BON $2.00
- ALZN $2.68
- Average True Range (ATR)
- BON 0.14
- ALZN 0.17
- MACD
- BON -0.02
- ALZN 0.02
- Stochastic Oscillator
- BON 32.56
- ALZN 74.00
About BON Bon Natural Life Limited
Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.